- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02165254
The Gentle Cardiac Rehabilitation Study
August 14, 2018 updated by: Elena Salmoirago-Blotcher, The Miriam Hospital
Development of A Tai-Chi Program To Overcome Barriers To Cardiac Rehabilitation
The purpose of this study is to develop a tai-chi based exercise program designed for patients who recently had a heart attack and do not wish, or are unable, to attend traditional cardiac rehabilitation.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
We will estimate the feasibility, acceptability and safety of two different doses of the Tai Chi intervention (primary outcome).
60 patients (30 per dose arm) will be randomly assigned to a standard dose of Tai Chi (the dose used by our group in large studies of heart failure patients) or to a high dose matching the recommended frequency and duration of exercise classes in current CRs.
Acceptability assessments will include surveys and focus groups to formally assess the impact of Tai Chi on facilitators and barriers to CRs in this population.
We will also obtain estimates of effect sizes of each dose on accelerometry measured physical activity and on the proportion of patients achieving the current American Heart Association (AHA) recommendation for physical activity (secondary outcome).
Additional outcomes will be cardiac fitness, quality of life, body weight, and sleep.
In addition, we will gather exploratory information on possible mechanisms by which Tai Chi training may affect physical activity.
We will collect information on possible mediators such as exercise self-efficacy, perceived social support, and depression.
In addition, since Tai Chi training is associated with meditative practices aimed at increasing present-moment awareness, we will gather information on mindfulness levels.
Measurements will be conducted at baseline, 3-, 6-, and 9 months after enrollment.
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- The Miriam Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 90 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able to understand and speak English
- Age ≥21
- Physically inactive
- Ability to understand the study procedures and willingness to commit to the demands of the study protocol
Exclusion Criteria:
- Inability or unwillingness to give informed consent
- Planning to move out of the area within the study period
- Unstable angina
- Blood pressure >200/110 or symptomatic orthostatic blood pressure decrease>20 mmHg
- Uncontrolled atrial or ventricular arrhythmias; 3rd degree Atrio-Ventricular block
- Pericarditis or myocarditis
- Recent embolism/thrombophlebitis
- Abnormal stress test without study cardiologist's clearance
- Medical conditions likely to limit lifespan
- NYHA functional class IV
- Signs of cognitive impairment (BOMC >10)
- Orthopedic problems prohibiting Tai Chi practice
- Ongoing Tai Chi or other mind-body training
- Current enrollment in a CR program
- Severe depression (HADS scores>14)
- Current drug or alcohol use or dependence that would interfere with adherence to study requirements.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: high dose tai chi intervention
|
1 hour tai chi session 3 times a week (weeks 1-12), to twice a week (week 13-16), and every other week (week 17-26) for a total of 24 weeks
|
|
Other: standard dose tai chi intervention
|
1 hour tai chi session 3 times a week (weeks 1-12)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
retention rates
Time Frame: up to 9 months since enrollment
|
up to 9 months since enrollment
|
|
drop-out rates
Time Frame: up to 9 months since enrollment
|
up to 9 months since enrollment
|
|
tai chi class attendance rates
Time Frame: up to 6 months since enrollment
|
up to 6 months since enrollment
|
|
number of participants with severe and non severe adverse events
Time Frame: up to 9 months since enrollment
|
up to 9 months since enrollment
|
|
percentage of participants reporting intervention acceptability scores in highest quartile
Time Frame: 3, 6, and 9 months since enrollment
|
3, 6, and 9 months since enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean between-group difference in within-participant change from baseline physical activity (accelerometry counts) over time (3, 6, and 9 months from enrollment)
Time Frame: baseline, 3, 6, 9 months
|
To estimate mean between-doses differences in physical activity (and other continuous secondary outcomes listed below), we will estimate multivariate linear mixed models for within-participant change since baseline as a function of dose group (high or low), time point (3, 6, and 9 months from enrollment, treated as a categorical variable to allow for non-linear trajectories), and their interaction.
A statistically significant interaction indicates that between-group differences vary across time points.
|
baseline, 3, 6, 9 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean between-group difference in within-participant change from baseline Short Form-36 quality of life scores over time (3, 6, and 9 months from enrollment)
Time Frame: baseline, 3,6, and 9 months
|
baseline, 3,6, and 9 months
|
|
Mean between-group difference in within-participant change from baseline HADS depression scores over time (3, 6, and 9 months from enrollment)
Time Frame: baseline, 3, 6, and 9 months
|
baseline, 3, 6, and 9 months
|
|
change from baseline aerobic capacity (METs)
Time Frame: baseline and intervention completion
|
baseline and intervention completion
|
|
Mean between-group difference in within-participant change from baseline Pittsburg Sleep Quality Index scores over time (3, 6, and 9 months from enrollment)
Time Frame: baseline, 3,6,9 months
|
baseline, 3,6,9 months
|
|
Mean between-group difference in within-participant change from baseline Five Facets of Mindfulness (FFM) scores over time (3, 6, and 9 months from enrollment)
Time Frame: baseline, 3,6, and 9 months
|
baseline, 3,6, and 9 months
|
|
Mean between-group difference in within-participant change from baseline Multidimensional Scale of Perceived Social Support scores over time (3, 6, and 9 months from enrollment)
Time Frame: baseline, 3, 6, 9 months
|
baseline, 3, 6, 9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Salmoirago-Blotcher E, Wayne P, Bock BC, Dunsiger S, Wu WC, Stabile L, Yeh G. Design and methods of the Gentle Cardiac Rehabilitation Study--A behavioral study of tai chi exercise for patients not attending cardiac rehabilitation. Contemp Clin Trials. 2015 Jul;43:243-51. doi: 10.1016/j.cct.2015.06.020. Epub 2015 Jun 24.
- Salmoirago-Blotcher E, Wayne PM, Dunsiger S, Krol J, Breault C, Bock BC, Wu WC, Yeh GY. Tai Chi Is a Promising Exercise Option for Patients With Coronary Heart Disease Declining Cardiac Rehabilitation. J Am Heart Assoc. 2017 Oct 11;6(10):e006603. doi: 10.1161/JAHA.117.006603.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2014
Primary Completion (Actual)
August 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
June 11, 2014
First Submitted That Met QC Criteria
June 16, 2014
First Posted (Estimate)
June 17, 2014
Study Record Updates
Last Update Posted (Actual)
August 16, 2018
Last Update Submitted That Met QC Criteria
August 14, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R34AT007569 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Secondary Prevention of Coronary Heart Disease
-
China National Center for Cardiovascular DiseasesChinese Academy of Medical SciencesRecruitingSecondary Prevention of Coronary Heart DiseaseChina
-
China National Center for Cardiovascular DiseasesCompletedSecondary Prevention of Coronary Heart DiseaseChina
-
Heart Care FoundationDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyNot yet recruitingAcute Coronary Syndromes | Secondary Prevention | LipidsItaly
-
BayerCompletedStroke | Coronary Heart Disease | Ischemic Heart Disease | Secondary PreventionUnited Kingdom
-
Universidad Miguel Hernandez de ElcheNot yet recruitingCardiovascular Diseases | Coronary Disease | Chronic Disease | Secondary PreventionSpain
-
Haukeland University HospitalYale University; University of Copenhagen; University of Bergen; The Research Council... and other collaboratorsRecruitingCoronary Artery Disease | Hypertension | Physical Activity | Adherence, Medication | Mental Health | Cardiac Rehabilitation | Comorbidities | Cost-Benefit Analysis | Adherence, Treatment | Health Literacy | Continuity of Patient Care | Women | Ethics | Secondary Prevention of Coronary Heart Disease | Older Adults (65... and other conditionsNorway
-
Vestre Viken Hospital TrustOslo University Hospital; The Hospital of Vestfold; Kalmar County HospitalCompleted
-
Tor Biering-SørensenNovartisNot yet recruitingCoronary Artery Disease | Hypercholesterolemia | Lipoprotein(a) | Secondary PreventionDenmark
-
University Hospital A CoruñaCompletedPhysical Activity | Acute Coronary Syndrome | Nutrition | Secondary PreventionSpain
-
Marna Rayl GreenbergCompletedCoronary Atherosclerosis | Prevention of Heart DiseaseUnited States
Clinical Trials on PLUS
-
Qure Healthcare, LLCLineagenCompletedIntellectual Disability | Developmental DelayUnited States
-
University of South CarolinaNational Cancer Institute (NCI); American Cancer Society, Inc.CompletedBreast CancerUnited States
-
Texas A&M UniversityUniversity of Arkansas; Arkansas Children's Hospital Research InstituteCompletedCystic FibrosisUnited States
-
The University of Tennessee, KnoxvilleNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Cherokee...CompletedObesity | Childhood ObesityUnited States
-
ResMedCompletedSleep Apnea, Obstructive | Sleep Apnea, CentralGermany
-
Alma Lasers Inc.Unknown
-
BioVersys AGNot yet recruitingTuberculosis Meningitis
-
Ethicon, Inc.Completed
-
Farmaceutici Damor SpaRecruitingWounds and Injuries | Wound Infection | Wound HealItaly
-
University of TrierGerman Research FoundationCompletedFeedback, PsychologicalGermany